Law360 Names Cravath a 2019 “M&A Practice Group of the Year”
January 17, 2020
On January 13, 2020, Cravath was featured as one of Law360’s “M&A Practice Groups of the Year,” receiving the distinction for the eighth time in nine years. The Firm was recognized for its “leading role in many of 2019’s mega‑deals,” as well as its success over the past year in cultivating “a diverse deal flow.”
The article highlights Cravath’s role advising Occidental through “rollercoaster takeover efforts” in its $57 billion acquisition of Anadarko; the Firm’s representation of Mylan in its pending $50 billion combination with Upjohn, structured as a Reverse Morris Trust transaction; and the representation of the Board Committee of Viacom in an all‑stock merger with CBS, reuniting the two companies after more than a decade apart.
Cravath partners Thomas E. Dunn and George F. Schoen are quoted in the feature. They each spoke on the unique complexities of the featured deals.
Related Practices & Industries
People
- Photo
-
-
J.D., 1992, Duke Law Schoolsumma cum laude
-
B.A., 1987, The College of William & Mary
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, University of Chicago Law Schoolwith Honors
-
B.A., 1994, Cornell University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
May 22, 2019
Occidental’s $57 Billion Acquisition of Anadarko, Contingent $8.8 Billion Sale of Anadarko African Assets to Total and $10 Billion Investment from Berkshire Hathaway
On May 9, 2019, Cravath client Occidental Petroleum Corporation (“Occidental”) entered into a definitive agreement whereby Occidental will acquire Anadarko Petroleum Corporation (“Anadarko”) for $59.00 in cash and 0.2934 shares of Occidental common stock per share of Anadarko common stock, in a transaction valued at $57 billion, including the assumption of Anadarko’s debt. This follows Occidental’s revised proposal to acquire Anadarko on May 5, 2019. (To read the announcement about the revised proposal, please click here.)
Deals & Cases
July 29, 2019
Mylan’s $50 Billion Combination with Upjohn, a Division of Pfizer
On July 29, 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, which is structured as an all-stock, Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. Cravath is representing Mylan in connection with the transaction.
Deals & Cases
August 13, 2019
Viacom’s Combination with CBS
On August 13, 2019, Viacom and CBS Corp. (“CBS”), two of the world’s leading entertainment companies, announced they have entered into a definitive agreement to combine in an all‑stock merger, creating a combined company with more than $28 billion in revenue. Cravath is representing the Board Committee of Viacom in connection with the transaction.
